GLOUP GROUP LTD

What GLOUP GROUP LTD does

GLOUP GROUP LTD operates as a niche UK consumer health e-commerce retailer and web portal operator, trading through the gloup.shop website under the registered legal entity Batherton Healthcare Limited. The company's core product is Gloup, a swallowing gel lubricant designed to make oral tablets, capsules, and vitamins easier to swallow for individuals with dysphagia, elderly patients on polypharmacy regimens, children transitioning off liquid medication, and clinical populations such as stroke survivors and Parkinson's patients. The formulation is built on a proprietary blend of carrageenan and maltodextrin with citric acid for saliva activation, and the product line is engineered to comply with IDDSI Level 3 (Original, Zero, Kids) and Level 4 (Forte) consistency standards; Gloup is classified as a Class 1 medical device with University of Brisbane clinical testing supporting safety equivalence to water.

The product range spans four sub-brands (Gloup Original, Gloup Zero sugar-free, Gloup Forte thicker formula, Gloup Kids) across 75ml tubes, 150ml tubes, and 500ml pump bottles, priced from £6.99 to £19.99 per unit. Revenue is generated through direct-to-consumer e-commerce sales on gloup.shop plus B2B/B2G invoice-based ordering (30-day terms) for NHS Trusts, PCTs, Foundation Trusts, GPs, care homes, universities, councils, and other public sector organizations. Distribution within the UK is handled via Royal Mail (orders under 2kg) and DPD Local (over 2kg), with free shipping above £30. The go-to-market blends content marketing, organic social (Facebook, Twitter, Instagram), email newsletters, healthcare trade show presence, and professional referrals from speech and language therapists.

The business is privately held with no disclosed external funding, no parent company, and no subsidiaries. Geographic operations are restricted to the United Kingdom, with explicit shipping limitations outside the UK. There are no disclosed acquisitions, leadership changes, regulatory actions, or management team details in the available data, and the firmographic year_founded of 2025 is inconsistent with operational artifacts dating to 2017, suggesting a recently restructured or holding-level incorporation.

Name

GLOUP GROUP LTD

Legal name

Batherton Healthcare Limited

Website

https://gloup.shop

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

GLOUP GROUP LTD is a UK-based e-commerce retailer operating gloup.shop, selling a proprietary swallowing gel lubricant (Gloup) for dysphagia patients, elderly users, and children, plus serving NHS Trusts and care homes via invoice-based institutional ordering.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Pharmacies and Drug Retailers (45611)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Health & Pharmacy Omnichannel (CRAFAEAK)

Keywords

• Swallowing gel lubricant
• Dysphagia medication aids
• Pill swallowing products
• Medication adherence solutions
• Medical device retail

Headquarters

HQ city

Narbonne

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Direct Product Sales: One-time purchase of swallowing gel products in various sizes (75ml, 150ml, 500ml) across multiple variants (Original, Zero, Forte, Kids). Revenue from individual consumers, care homes, and NHS/healthcare institutions.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Gloup Group operates as an e-commerce retailer and web portal operator (via gloup.shop) selling Gloup, a Class 1 medical device swallowing gel formulated with carrageenan and maltodextrin to help patients swallow tablets, capsules, and vitamins whole. The company offers multiple variants (Original, Zero sugar-free, Kids, and Forte thicker formula) in tube and pump-bottle formats, and distributes to individual consumers, care homes, and NHS/public sector organisations across the UK.

Product overview

Gloup is a range of swallowing gels designed to make tablets, capsules, and vitamins easier to swallow. The product line consists of three sub-brands: Gloup Original (standard formulation with sucrose), Gloup Zero (sugar-free version using xylitol), and Gloup Kids (child-specific formulation). An additional variant, Gloup Forte, provides a thicker consistency for patients with more severe swallowing difficulties. Products are available in multiple formats (75ml tubes, 150ml tubes, 500ml pump bottles) and serve patients with dysphagia, Parkinson's, stroke survivors, elderly patients, children transitioning from liquid medication, and anyone with difficulty swallowing pills. Gloup is a Class 1 medical device with no known interactions with medication, free from gluten, allergens, and gelatine, and suitable for vegetarians.

Differentiator

Problem solved

Functional benefit

Brands

• Gloup Original: The original swallowing gel product line available in 75ml, 150ml, and 500ml sizes. Contains 100% natural ingredients and is IDDSI level 3. Contains sucrose as sweetening agent.
• Gloup Zero
• Gloup Forte
• Gloup Kids

Products and services

• Gloup Original 75ml Tube Swallowing gel lubricant in a 75ml plastic tube with flip-top cap, designed to make solid pills and capsules easier to swallow. Formulated with 100% natural ingredients including carrageenan, maltodextrin, sucrose, potassium sorbate, calcium chloride, and citric acid. IDDSI level 3. Sold for £6.99 per tube.
• Gloup Original 150ml Tube Swallowing gel in a 150ml plastic tube with flip-top cap for easier medication intake. Formulated with natural ingredients, suitable for vegetarians, IDDSI level 3. Sold for £8.99 per tube.
• Gloup Original 500ml Bottle with Pump Swallowing gel in a 500ml pump bottle with dispenser for institutional or frequent use. Dosage per full dispenser movement is 5ml. IDDSI level 3. Sold for £19.99 per bottle.
• Gloup Zero 75ml Tube (Sugar Free) Sugar-free version of the swallowing gel in a 75ml tube, using xylitol as the sweetening agent instead of sucrose. Designed for those monitoring sugar intake. IDDSI level 3. Sold for £6.99 per tube.
• Gloup Zero 150ml Tube (Sugar Free) Sugar-free swallowing gel in a 150ml tube with raspberry flavour. Contains xylitol as sweetener, free from gluten and gelatine. IDDSI level 3. Sold for £8.99 per tube.
• Gloup Zero 500ml Bottle (Sugar Free)

Quantifiable outcome

• Saves 15-20 minutes per medication round for care homes with 21 residents
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• University of BrisbanecoreStrategic or Co-development PartnerConducted clinical testing proving that intake of medication with Gloup is as safe as intake with water. Tests validated the formulation's safety and efficacy for medication administration.
• IDDSI (International Dysphagia Diet Standardisation Initiative)coreOthersGloup Original and Zero are formulated to IDDSI level 3, while Gloup Forte is formulated to IDDSI level 4, meeting international dysphagia diet standards.

Scale indicators6 records

Recent moves1 record

Expansion highlights4 records

Broad incumbents

• Nestlé Health Science: Nestlé Health Science is a global medical nutrition leader offering dysphagia and thickening products (e.g., Resource ThickenUp) and is a natural strategic acquirer or competitive incumbent in the dysphagia medication-administration space Gloup serves.
• Fresenius Kabi: Fresenius Kabi provides clinical nutrition, thickened fluids (e.g., Fresubin) and dysphagia-focused products globally. It is a relevant incumbent in the broader dysphagia clinical-nutrition market that Gloup serves.
• Abbott Nutrition: Abbott Nutrition provides thickened nutrition products for dysphagia patients across institutional and consumer channels. It is a major incumbent that could replicate Gloup's medication-lubricant niche through its established medical sales force.
• Danone Nutricia: Danone's Nutricia division offers medical nutrition products including dysphagia solutions (Nutilis) across European markets. As an established incumbent in dysphagia nutrition, it competes with Gloup for SLT and NHS recommendations.

Direct peers

• Thick-It (Hormel Health Labs): Thick-It is a food and beverage thickener for people with swallowing difficulties, owned by Hormel Health Labs. It competes in the same IDDSI-standard dysphagia category that Gloup Forte addresses.
• Fagron (Pill Glide): Fagron distributes Pill Glide, a spray-based medication swallowing lubricant, the closest direct substitute to Gloup's gel format. Both target dysphagia patients with a purpose-designed lubricant and sell through consumer and institutional channels.
• SimplyThick: SimplyThick is a leading xanthan-based thickening gel for dysphagia patients that mixes with beverages and food. It overlaps with Gloup Forte (IDDSI Level 4) and addresses the same dysphagia patient population and IDDSI framework.
• MedGlide: MedGlide is a flavoured spray lubricant specifically designed to help patients swallow pills and tablets. It is the most directly comparable product format to Gloup, competing in the same dysphagia and pill-swallowing use case.

Emerging players

• FlavourCrete (Swallow Aid): Swallow Aid is a UK-based emerging competitor offering pill-swallowing sprays and aids targeting the same dysphagia patient segments. It is a smaller, niche challenger operating in Gloup's home market.

Others

• Sussex Healthcare: Sussex Healthcare is a UK care home operator and ecosystem participant. It is comparable not as a product peer but as an institutional customer channel — care homes are central buyers of Gloup's institutional volume.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/Gloup_UK
• Facebookfacebook.com/GloupUK
• Instagraminstagram.com/GloupUK

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GLOUP GROUP LTD